Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

Background: Poly (ADP-ribose) polymerase (PARP) inhibitor and antiangiogenic agent monotherapy have shown to be effective as maintenance treatment in patients with ovarian cancer (OC). However, there is currently a lack of evidence-based study to directly compare the effects of combination therapy w...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yan Wei, Li He, Tao Liu, Tao Guo, Cong Xie, Jigang Jia, Yonghong Lin, Jiang Liu, Jiayin Fan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2024-03-01
Schriftenreihe:	Frontiers in Pharmacology
Schlagworte:	PARP inhibitors antiangiogenic agents olaparib bevacizumab ovarian cancer combination therapy
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1372077/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!